Summary of Significant Accounting Policies (Details) - $ / shares |
3 Months Ended | |||
|---|---|---|---|---|
Mar. 31, 2022 |
Dec. 31, 2021 |
Mar. 31, 2021 |
Nov. 30, 2019 |
|
| Warrants, exercise price | $ 5.19 | $ 0.001 | ||
| Potentially dilutive shares outstanding (in shares) | 1,382,402 | |||
| Pre Funded Warrants | ||||
| Warrants issued to purchase shares of common stock | 253,828 | 253,828 | ||
| Warrants, exercise price | $ 0.001 |
| X | ||||||||||
- Definition Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|